Cargando…

A Third Dose of SARS-CoV-2 mRNA Vaccine Improves Immune Response in Chronic Kidney Disease Patients

Chronic kidney disease (CKD) patients have an increased risk of morbidity and mortality following SARS-CoV-2 infection. Vaccination in these patients is prioritized, and monitoring of the immune response is paramount to define further vaccination strategies. This prospective study included a cohort...

Descripción completa

Detalles Bibliográficos
Autores principales:	Poli, Maria Cecilia, Vial, Cecilia, Rey-Jurado, Emma, González, Natalia, Cortés, Lina Jimena, Hormazabal, Juan, Ramírez-Riffo, Carolina, de la Cruz, Javiera, Ulloa, Camilo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10221173/ https://www.ncbi.nlm.nih.gov/pubmed/37243116 http://dx.doi.org/10.3390/vaccines11051012

Ejemplares similares

Deep immunophenotyping reveals biomarkers of multisystemic inflammatory syndrome in children in a Latin American cohort
por: Rey-Jurado, Emma, et al.
Publicado: (2022)

SARS-CoV-2 Neutralizing Antibodies in Chile after a Vaccination Campaign with Five Different Schemes
por: Aguilera, Ximena, et al.
Publicado: (2022)

Factors influencing neutralizing antibody response to the original SARS-CoV-2 virus and the Omicron variant in a high vaccination coverage country, a population-based study
por: Hormazábal, Juan, et al.
Publicado: (2023)

Seroprevalence of Natural and Acquired Immunity against the SARS-CoV-2 Virus in a Population Cohort from Two Chilean Cities, 2020–2022
por: Núñez-Franz, Loreto, et al.
Publicado: (2023)

Immunization and SARS-CoV-2 Antibody Seroprevalence in a Country with High Vaccination Coverage: Lessons from Chile
por: Aguilera, Ximena, et al.
Publicado: (2022)

Assessing Pulmonary Epithelial Damage in Hantavirus Cardiopulmonary Syndrome: Challenging the Predominant Role of Vascular Endothelium through sRAGE as a Potential Biomarker
por: Meza-Fuentes, Gabriela, et al.
Publicado: (2023)

Randomized Trial of a Third Dose of mRNA-1273 Vaccine in Transplant Recipients
por: Hall, Victoria G., et al.
Publicado: (2021)

Evolution of antibody titers after two doses of mRNA Pfizer-BioNTech vaccine and effect of the third dose in nursing home residents
por: Rodríguez-Avial, Iciar, et al.
Publicado: (2023)

Third dose of an mRNA COVID-19 vaccine for patients with multiple myeloma
por: Goldwater, Marissa-Skye, et al.
Publicado: (2023)

Hemodynamic and Pulmonary Permeability Characterization of Hantavirus Cardiopulmonary Syndrome by Transpulmonary Thermodilution
por: López, René, et al.
Publicado: (2019)

Immunogenicity to COVID-19 mRNA vaccine third dose in people living with HIV
por: Vergori, Alessandra, et al.
Publicado: (2022)

Acute myocarditis after the third dose of COVID‐19 mRNA‐1273 vaccine
por: Yamada, Takayuki
Publicado: (2023)

Booster effect of the third dose of SARS-CoV-2 mRNA vaccine in Japanese kidney transplant recipients
por: Kawabe, Mayuko, et al.
Publicado: (2023)

Evaluation of the Immune Response Induced by CoronaVac 28-Day Schedule Vaccination in a Healthy Population Group
por: Escobar, Alejandro, et al.
Publicado: (2022)

Antibody Responses to Third-Dose mRNA Vaccines in Nursing Home and Assisted Living Residents
por: Zhang, Ali, et al.
Publicado: (2022)

Severe Acute Myocarditis after the Third (Booster) Dose of mRNA COVID-19 Vaccination
por: Mengesha, Bethlehem, et al.
Publicado: (2022)

Improved Immune Response to the Third COVID-19 mRNA Vaccine Dose in Hemodialysis Patients
por: Kanai, Daisuke, et al.
Publicado: (2022)

Acute myocarditis following a third dose of COVID-19 mRNA vaccination in adults
por: Simone, Anthony, et al.
Publicado: (2022)

Myopericarditis Following the Third Dose of COVID-19 mRNA Vaccination: A Case Report
por: Saeed, Aamir, et al.
Publicado: (2023)

Safety and immunogenicity of a third dose of mRNA‐1273 vaccine among cancer patients
por: Giuliano, Anna, et al.
Publicado: (2023)

Different antibody responses between liver and kidney transplant recipients elicited by third doses of COVID-19 mRNA vaccines
por: Lim, So Yun, et al.
Publicado: (2023)

Understanding the dosing-time-dependent antihypertensive effect of valsartan and aspirin through mathematical modeling
por: Cortés-Ríos, Javiera, et al.
Publicado: (2023)

Persistent SARS-CoV-2–specific immune defects in kidney transplant recipients following third mRNA vaccine dose
por: Werbel, William A., et al.
Publicado: (2023)

Waning effectiveness of the third dose of the BNT162b2 mRNA COVID-19 vaccine
por: Patalon, Tal, et al.
Publicado: (2022)

Myocarditis After the Third Dose of mRNA-1273 Coronavirus Disease 2019 (COVID-19) Vaccine
por: Kawahara, Hiroshi, et al.
Publicado: (2022)

Delayed urticaria after the third dose of mRNA COVID19 vaccine: A case series
por: Bianchi, Leonardo, et al.
Publicado: (2022)

Ulcerative injection site reaction after third COVID‐19 vaccine dose with mRNA‐1273
por: Barei, Francesca, et al.
Publicado: (2022)

Third dose of COVID-19 mRNA vaccine appears to overcome vaccine hyporesponsiveness in patients with cirrhosis
por: John, Binu V., et al.
Publicado: (2022)

Humoral and cellular immune responses in persons with rheumatoid arthritis after a third dose of mRNA COVID-19 vaccine
por: Tedeschi, Sara K., et al.
Publicado: (2023)

Safety and Adverse Events Among Long-term Care Residents Receiving a Third COVID-19 mRNA Vaccine Booster Dose in Quebec
por: Zhang, Xi Sophie, et al.
Publicado: (2022)

Safety and Immunogenicity of a Third Dose of SARS-CoV-2 mRNA Vaccine – An Interim Analysis
por: Anderson, Evan, et al.
Publicado: (2022)

Poor vaccine responsiveness towards third-dose mRNA vaccine of COVID-19 in Japanese older people
por: Hagiya, Hideharu, et al.
Publicado: (2022)

Longitudinal Comparison of Neutralizing Antibody Responses to COVID-19 mRNA Vaccines after Second and Third Doses
por: Roeder, Alexa J., et al.
Publicado: (2022)

Antibody Response against Circulating Omicron Variants 8 Months after the Third Dose of mRNA Vaccine
por: Anichini, Gabriele, et al.
Publicado: (2022)

Association Between Fever and Antibody Titer Trends After a Third Dose of the mRNA-1273 Vaccine
por: Matsumoto, Naomi, et al.
Publicado: (2022)

Booster Effect of a Third mRNA-Based COVID-19 Vaccine Dose in Patients with Myeloid Malignancies
por: Mori, Akio, et al.
Publicado: (2022)

Booster effect of a third mRNA‐based COVID‐19 vaccine dose in patients with myeloid malignancies
por: Mori, Akio, et al.
Publicado: (2023)

A Third Dose of mRNA COVID-19 Vaccine Significantly Enhances Anti–SARS-CoV-2 Spike IgG Response in Nursing Home Residents in Italy
por: Fedele, Giorgio, et al.
Publicado: (2022)

Third-dose SARS-CoV-2 mRNA vaccine increases Omicron variant neutralization in patients with chronic myeloid disorders
por: Harrington, Patrick, et al.
Publicado: (2022)

Dosing time optimization of antihypertensive medications by including the circadian rhythm in pharmacokinetic-pharmacodynamic models
por: Cortés-Ríos, Javiera, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_6qcr2opu63oe6h23onricrl1nv